SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity - Poll - MDSpire

SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity

  • By

  • Barbara Pala

  • Mariagrazia Piscione

  • Maria Carmela Di Marcantonio

  • Francesco Cribari

  • Roberta Vitale

  • Thomas Baldi

  • Ada Popolo

  • Gabriella Mincione

  • June 9, 2026

  • 0 min

Share

Original Source(s)

SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity

  • by Barbara Pala, Mariagrazia Piscione, Maria Carmela Di Marcantonio, Francesco Cribari, Roberta Vitale, Thomas Baldi, Ada Popolo, Gabriella Mincione

  • June 9, 2026

Related Content

Congestive heart failure and comorbidity as determinants of colorectal cancer perioperative outcomes

Prevalence of asymptomatic atrial fibrillation and risk factors associated with asymptomatic status: a systematic review and meta-analysis

Early detection value of miR-29a in patients with acute myocardial infarction